Top Story

FDA advises on medication-assisted treatment for individuals taking depressants

FDA advises on medication-assisted treatment for individuals taking depressants
September 20, 2017

The FDA today issued a Drug Safety Communication advising that buprenorphine and methadone should not be withheld from individuals receiving benzodiazepines or other medications that depress the central nervous system.

The communication also stated that although combined use of these medications increases risk for serious side effects, harm caused by untreated opioid addiction outweighs these risks.

Meeting News

Expert addresses top clinical challenges in substance use disorder treatment

September 19, 2017
NEW ORLEANS — In a session here, Thomas R. Kosten, MD, of Baylor College of Medicine and MD Anderson Cancer Center, Houston, discussed top clinical challenges in…
Meeting NewsVideo

VIDEO: How cannabis policies will affect psychiatric practice

September 18, 2017
NEW ORLEANS — Twenty-nine states and Washington D.C. have medical cannabis policies and 9 states and Washington, D.C. have legalized recreational cannabis
Meeting News

Using music to break barriers in homelessness, mental health

September 17, 2017
NEW ORLEANS — In a session here at Psych Congress, Vijay Gupta, MM, director of Street Symphony and violinist, illustrated the power of music in mental health and…
More Headlines »
CME Article

Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C

Psychiatric Annals, January 2017, Volume 47 Issue 1
Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human…
More »

The Patient with Major Depressive Disorder (MDD)

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with major depressive disorder (MDD).
More »
Resource Centers
Psych Congress

Psych Congress

Meeting News Coverage

VIDEO: Using naloxone for lay opioid overdose reversal

June 8, 2016
More »